Evidence map›Paper›PMID 26272550›Full record

ArticleChinese journal of integrative medicine2018

In Vitro Angiogenesis Effect of Xuefu Zhuyu Decoction () and Vascular Endothelial Growth Factor: A Comparison Study.

Fan Lin, Bin-Ling Chen, Yi-Zheng Wang, Dong Gao, Jun Song, T J Kaptchuk, Ke-Ji Chen

Open access · greenAbstract readComparative Study
In one paragraph

Article in Chinese journal of integrative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Fan LinCollege of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.
Bin-Ling ChenThe Second Hospital of Longyan, Longyan, Fujian Province, 364000, China.
Yi-Zheng WangCollege of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.
Dong GaoCollege of Integrative Medicine, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China. 976558160@qq.com.
Jun SongExperimental Research Center, China Academy of Chinese Medical Sciences, Beijing, 100700, China. junsong86@sohu.com.
T J KaptchukBeth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.
Ke-Ji ChenXiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China.
Fujian University of Traditional Chinese Medicine · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNHarvard University · USLongyan University · CN

Funding

Mentoring and Research in Placebo Studies, Asian Medicine, and CAMK24AT004095 · NCCIH · HARVARD MEDICAL SCHOOL · PI KAPTCHUK, TED · 2007 to 2016
$1.4M
NCCIH NIH HHS K24 AT004095
6 · The paper itself

Abstract

objectiveTo compare the angiogenesis behaviors of vascular endothelial growth factor (VEGF) and Chinese medicine Xuefu Zhuyu Decoction (, XZD) treatments.

methodsHuman microvascular endothelial cells (HMEC-1) were treated with various concentrations of either XZD-containing serum (XZD-CS) or VEGF for 24, 48, and 72 h, respectively. Cell viability, proliferation, migration, adhesion, and in vitro tube formation assays were used to assess their angiogenic effects.

resultsVEGF promoted all cellular phases involved in angiogenesis including cell viability, proliferation, migration, adhesion, and tube formation (<0.05 or <0.01). Unlike the continuous promotion effects of VEGF at the above stages, XZD inhibited cell viability and proliferation (<0.05 or <0.01) and only promoted tube formation in the early phase of angiogenesis (<0.01).

conclusionsThese two medications promote different angiogenesis behaviors, which might be an important reason for their distinct therapeutic profile in clinical usage.

Indexed as

Cell AdhesionCell CycleCell LineCell MovementCell ProliferationCell SurvivalDrugs, Chinese HerbalEndothelial CellsHumansMicrovesselsNeovascularization, PhysiologicVascular Endothelial Growth Factor ADrugs, Chinese HerbalVascular Endothelial Growth Factor AXue-Fu-Zhu-Yu decoctionangiogenesisChinese medicinevascular endothelial growth factorXuefu Zhuyu Decoction

Identifiers

PMID26272550
PMCPMC4779078
OpenAlexW1451434975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.